Endologix Company Profile (NASDAQ:ELGX)

Analyst Ratings

Consensus Ratings for Endologix (NASDAQ:ELGX) (?)
Ratings Breakdown: 10 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.55 (2.46% upside)

Analysts' Ratings History for Endologix (NASDAQ:ELGX)
Show:
DateFirmActionRatingPrice TargetActions
7/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2016BMO Capital MarketsUpgradeMarket Perform -> Outperform$11.50 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Piper Jaffray Cos.Reiterated RatingOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Royal Bank Of CanadaBoost Price TargetOutperform$15.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016GuggenheimInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016BTIG ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016JPMorgan Chase & Co.Initiated CoverageOverweight$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Credit Suisse Group AGLower Price TargetOutperform$16.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Stifel NicolausLower Price TargetBuy$17.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Endologix (NASDAQ:ELGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
5/9/2016Q1($0.24)($0.25)$38.78 million$42.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q4($0.16)($0.17)$39.97 million$39.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2015Q315($0.14)($0.13)$38.12 million$38.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215($0.13)($0.18)$39.47 million$39.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115($0.13)($0.14)$37.94 million$36.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.10)($0.11)$38.10 million$38.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.13)($0.13)$37.00 million$37.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214($0.08)($0.06)$36.50 million$38.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114($0.08)($0.08)$32.24 million$33.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.05)($0.05)$35.80 million$35.25 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313($0.05)$0.01$32.47 million$33.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013($0.06)($0.03)$33.94 million$34.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013($0.06)($0.15)$29.26 million$29.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013Q4 2012($0.03)($0.09)$29.03 million$29.22 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.04)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.04)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012($0.06)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.05)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011($0.05)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endologix (NASDAQ:ELGX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.24)($0.24)($0.24)
Q2 20161($0.22)($0.22)($0.22)
Q3 20161($0.18)($0.18)($0.18)
Q4 20161($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endologix (NASDAQ:ELGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endologix (NASDAQ:ELGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Gregory D WallerDirectorSell7,800$12.86$100,308.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Amanda L DepalmaVPSell689$12.55$8,646.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016John D McdermottCEOSell6,116$12.55$76,755.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Joseph A DejohnInsiderSell957$12.55$12,010.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Robert D MitchellPresidentSell2,294$12.55$28,789.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016James Edward MachekVPSell6,500$12.76$82,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2016Charles Steele LoveVPSell4,280$7.72$33,041.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Guido J NeelsDirectorBuy11,000$9.32$102,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Todd AbrahamVPBuy2,500$8.85$22,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015John D McdermottCEOBuy20,000$8.90$178,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Jose A LimaVPSell1,923$12.60$24,229.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Thomas WilderDirectorSell3,790$16.08$60,943.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Jose A LimaVPSell1,872$16.75$31,356.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Robert D MitchellPresidentSell45,000$17.33$779,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Charles Steele LoveVPSell10,000$13.95$139,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Charles Steele LoveVPBuy2,000$11.70$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Guido J NeelsDirectorBuy10,000$11.21$112,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014John D McdermottCEOBuy25,000$11.25$281,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Thomas WilderDirectorSell3,500$13.68$47,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Robert D MitchellPresidentSell18,271$14.23$259,996.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Robert D MitchellPresidentSell8,516$14.20$120,927.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Stefan SchreckVPSell25,000$16.18$404,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Stefan SchreckVPSell29,000$15.88$460,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Gary SorsherVPSell12,483$15.98$199,478.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013John McdermottCEOSell165,000$16.00$2,640,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Todd AbrahamVPSell9,994$15.90$158,904.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013John D McdermottCEOSell15,000$15.83$237,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Thomas WilderDirectorSell22,500$13.25$298,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Leonard M GreensteinVPSell1,253$14.01$17,554.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2012Robert John KristCFOSell37,530$14.06$527,671.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Endologix (NASDAQ:ELGX)
DateHeadline
07/22/16 06:50 AMEndologix, Inc. (NASDAQ:ELGX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 06:55 AMEquity Roundup: Stock Performance Focus on Endologix, Inc. (NASDAQ:ELGX) - Press Telegraph
07/19/16 03:53 PMShare Performance Summary for: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph
07/19/16 03:53 PMEarnings Focus and Crowd Sourced Sentiment Review for Endologix, Inc. (NASDAQ:ELGX) - TGP
07/19/16 03:53 PMStock Focus: Following Analyst Expectations on Shares of Endologix, Inc. (NASDAQ:ELGX) - TGP
07/17/16 08:19 AMShares Moving Down on the Week: Endologix Inc. (NASDAQ:ELGX) - Engelwood Daily
07/14/16 03:27 PMEndologix Incorporated (NASDAQ:ELGX) Short Interest Increased By 25.37% - Press Telegraph
07/14/16 04:19 AMAnalyst Target and Average Rating Watch: Endologix, Inc. (NASDAQ:ELGX) - Press Telegraph
07/12/16 09:08 PMStock Providing Gains on the Month for Investors: Endologix Inc. (NASDAQ:ELGX) - Telanagana Press
07/12/16 09:08 PMStock Performance Rundown on: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph
07/12/16 09:08 PMHow Many Endologix, Inc. (NASDAQ:ELGX)'s Analysts Are Bullish? - Consumer Eagle
07/12/16 08:00 AMEndologix to Report Second Quarter 2016 Financial Results on August 2, 2016 - [GlobeNewswire] - IRVINE, Calif., July 12, 2016-- Endologix, Inc., developer and marketer of innovative treatments for aortic disorders, announced today details relating to the release of its second quarter 2016 financial ...
07/09/16 07:18 AMWill Endologix, Inc. (NASDAQ:ELGX) Surprise Analysts? - Investor Newswire
07/09/16 07:18 AMAnalysts Review of Stocks: Exelixis, Inc. (NASDAQ:EXEL) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates
07/09/16 07:18 AMEndologix, Inc. (ELGX) – Product Pipeline Analysis, 2016 according to market demands - Medgadget (blog)
07/08/16 03:50 PMResearch details developments in the Endologix, Inc. (ELGX) – Product Pipeline Analysis, 2016 Update
07/08/16 07:18 AMResearch details developments in the Endologix, Inc. (ELGX) – Product Pipeline Analysis, 2016 Update - Medgadget (blog)
07/07/16 03:49 PMBMO's Physician Survey Results Indicate Good Health Of Endologix
07/06/16 09:39 PMCompany Stock Focus for Endologix, Inc. (NASDAQ:ELGX): Which Way Will Shares Head? - Press Telegraph
07/04/16 03:32 PMShare Performance Recap for: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph
07/01/16 07:10 AMCovering the Bases on Endologix, Inc. (NASDAQ:ELGX): Where is the Stock Going? - Press Telegraph
06/28/16 07:39 AMEndologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : June 28, 2016 -
06/27/16 03:45 PMNext Weeks Broker Price Targets For Endologix, Inc. (NASDAQ:ELGX) - Fiscal Standard
06/27/16 08:17 AMStock Performance Focus on: Endologix Inc. (NASDAQ:ELGX) - Press Telegraph
06/23/16 02:46 PMEndologix, Inc. (NASDAQ:ELGX) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 06:17 AMEarnings Recap: Endologix Inc. (NASDAQ:ELGX) - iStreetWire
06/23/16 06:17 AMRecently Issued Stock Ratings For Endologix, Inc. (NASDAQ:ELGX) - Fiscal Standard
06/15/16 03:53 PMAnalysts and Technical Report on Endologix Inc (NASDAQ:ELGX) - Street Report
06/14/16 08:38 AMStocks Earnings Review: Endologix Inc. (NASDAQ:ELGX), Wynn Resorts Ltd. (NASDAQ:WYNN) - Beacon Chronicle
06/14/16 08:38 AMEndologix (ELGX) Is Today's Strong On High Volume Stock - TheStreet.com
06/13/16 03:35 PMPrice Target Summary Report: Pinnacle Foods Inc. (NYSE:PF), Endologix Inc. (NASDAQ:ELGX) - Beacon Chronicle
06/13/16 11:58 AMEndologix System Could Be ‘Game Changer’ In Aneurysm Repair -
06/13/16 07:12 AMAnalysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More -
06/11/16 07:40 AMTrend Of Rating Given To Endologix, Inc. (NASDAQ:ELGX) - Investor Newswire
06/11/16 07:40 AMAnalysts Reviewing Stocks: Endologix, Inc. (NASDAQ:ELGX) , Cigna Corporation (NYSE:CI) - Street Updates
06/10/16 07:46 AMEarnings Overview of the Stocks: Endologix Inc. (NASDAQ:ELGX), Colgate-Palmolive Co. (NYSE:CL) - Beacon Chronicle
06/09/16 09:54 PMBest Stocks for Investors: Endologix Inc. (NASDAQ:ELGX), CMS Energy Corp. (NYSE:CMS) - Beacon Chronicle
06/09/16 03:52 PMEndologix Inc. (NASDAQ:ELGX) Fundamental Star Rating Report - CML News
06/09/16 11:09 AMStocks inside Traders Spotlight: Endologix, Inc. (NASDAQ:ELGX) , Incyte Corporation (NASDAQ:INCY) - Street Updates
06/09/16 08:49 AMEndologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy - [at noodls] - June 9, 2016 Results Presented at 2016 Society of Vascular Surgery Annual Meeting IRVINE, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments ...
06/09/16 08:34 AM9:34 am Endologix announces 'positive' clinical data from the Italian Research Nellix Endoprosthesis study at the 2016 Society of Vascular Surgery annual meeting -
06/08/16 02:46 PMBuy Stocks for Investors: Endologix Inc. (NASDAQ:ELGX), Intrepid Potash, Inc. (NYSE:IPI) - Beacon Chronicle
06/08/16 08:12 AMTrending Stock Analysis: Endologix Inc. (NASDAQ:ELGX) - News Oracle
06/07/16 09:29 PMENDOLOGIX INC. (NASDAQ:ELGX) Financial Condition Compared to S&P 500 - CML News
06/07/16 03:55 PMAnalyst Recommended Buy These Stocks: Endologix Inc. (NASDAQ:ELGX), Deutsche Bank AG (NYSE:DB) - Beacon Chronicle
06/07/16 05:02 AMENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
06/06/16 03:42 PMEndologix, Inc. (NASDAQ:ELGX) & Lion Biotechnologies (NASDAQ:LBIO) healthcare - Wall Street 24
06/06/16 03:42 PMAnalyst Recommended Stock: Endologix Inc. (NASDAQ:ELGX) - News Oracle
06/06/16 07:08 AMNotable HC Stocks Preview: Endologix, Inc. (NASDAQ:ELGX), Express Scripts Holding Company (NASDAQ:ESRX) - share market updates (press release)
06/03/16 08:23 AM957 Shares of Endologix, Inc. (ELGX) Stock are sold by Joseph A. Dejohn - Let Me Know About This - 957 Shares of Endologix, Inc. (ELGX) Stock are sold by Joseph A. DejohnLet Me Know About ThisEndologix logo Endologix, Inc. (NASDAQ:ELGX) insider Joseph A. Dejohn sold 957 shares of the company's stock in a transaction on Wednesday, June 1st. The stock was sold at an average price of $12.55, for a total value of $12,010.35. Following the sale ...Endologix, Inc. (NASDAQ:ELGX)'s Insider John Mcdermott Sold 6116 SharesFranklin IndependentEndologix, Inc. (NASDAQ:ELGX) Trading Up - Insiders Selling, Short Interest GrowingFinance Dailyall 10 news articles »

Social

About Endologix

Endologix logoEndologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ELGX
  • CUSIP: 29266S10
Key Metrics:
  • Previous Close: $14.20
  • 50 Day Moving Average: $13.10
  • 200 Day Moving Average: $10.39
  • P/E Ratio: N/A
  • P/E Growth: -0.47
  • Market Cap: $1.16B
  • Beta: 0.69
  • Current Year EPS Consensus Estimate: $-0.79 EPS
  • Next Year EPS Consensus Estimate: $-0.67 EPS
Additional Links:
Endologix (NASDAQ:ELGX) Chart for Wednesday, July, 27, 2016